Journals / Glokom Katarakt / 2021 / Cilt: 16 - Sayı: 2

Effect of the Transscleral Diode Laser Cyclophotocoagulation Treatment in Refractory Glaucoma Patients

Pages
98–105
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Mean intraocular pressure was 44.1±11.3 mmHg at baseline, which reduced to 17.0±9.8 mmHg at year 1 (%63.4) (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:study, it was aimed to assess effi cacy of diode laser cyclophotocoagulation in reducing intraocular pressure in refractory glaucoma patients.
📊
Key Findings & Data:Material and Methods: The study included patients followed with diagnosis of refractory glaucoma; newly diagnosed refractory glaucoma patients presented to our glaucoma clinic between January 2008 and May 2011.
💡
Conclusion & Impact:Mean intraocular pressure was 44.1±11.3 mmHg at baseline, which reduced to 17.0±9.8 mmHg at year 1 (%63.4) (p
🔬Design:Research Article
📍Scope:2008 Verileri
⚙️Variables:Domain Parameters

Abstract

study, it was aimed to assess effi cacy of diode laser cyclophotocoagulation in reducing intraocular pressure in refractory glaucoma patients. Material and Methods: The study included patients followed with diagnosis of refractory glaucoma; newly diagnosed refractory glaucoma patients presented to our glaucoma clinic between January 2008 and May 2011. In all patients, visual acuity, intraocular pressure as measured by Goldmann applanation tonometry, fi ndings of slit-lamp examination and fundus examination, glaucoma type, number of medications, previous glaucoma surgeries were recorded at baseline. In all patients, intraocular pressure was measured at baseline and on day 1, on week 1and 6, and at month 3, 6 and 12 after treatment. Results: The study included 49 of 49 patients (18 female, 29 male). Mean age was 61.4±12.8 years. In the study group, there were 25 patients (%51.2) with neovascular glaucoma, 9 patients (%18.4) with primary open angle glaucoma, 6 patients (%12.2) with primary angle closure glaucoma, 4 patients (%8.2) with pseudoexfoliation glaucoma and 5 patients (%10.2) with secondary glaucoma. Mean intraocular pressure was 44.1±11.3 mmHg at baseline, which reduced to 17.0±9.8 mmHg at year 1 (%63.4) (p

🔖

Cite This Article

ŞAHİN, B. Ö., KAYIKÇIOĞLU, R. Ö. (2022). Effect of the Transscleral Diode Laser Cyclophotocoagulation Treatment in Refractory Glaucoma Patients. Glokom Katarakt, Cilt: 16 - Sayı: 2, 98–105. https://ajindex.com/articles/525726

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. European Glaucoma Society. Terminology and guidelines for glaucoma
  2. Savona: Publi Comm; 2014
  3. Feldmann RM, El-Harazi SM, LoRusso FJ, et al. Histopathologic fi ndings following contact transscleral semiconductor diode laser cyclophotocoagulation in a human eye. J Glaucoma. 1997;6:139-40
  4. Dastiridou AI, Katsanos A, Denis P, et al. Cyclodestructive Procedures in Glaucoma: A Review of Current and Emerging Options. Adv Ther. 2018;35:2103-27
  5. Iliev M E, Gerber S. Long-term outcome of trans-scleral diode laser cyclophotocoagulation in refractory glaucoma. Br J Ophthalmol 2007;91:1631-5
  6. Mistbelger A, Liebman JM, Tschiderer H, et al. Diode lazer transscleral cyclophotocoagulation for refractoy glaucoma. J Glaucoma 2001;10:288-93
  7. Kosoko O, Gaasterland DE, Pollack IP, et al. The Diode Laser Ciliary Ablation Study Group. Long-term outcome of initial ciliary ablation with contact diode laser transscleral cyclophotocoagulation for severe glaucoma. Ophthalmology 1996;103:1294-302
  8. Rebolleda G, Munoz FJ, Murube J. Audible pops during cylodiode procedures. J Glaucoma 1999;8:177-83
  9. Bloom PA, Tsai JC, Sharma K, et al. “Cyclodiode”. Trans-scleral diode laser cyclophotocoagulation in the treatment of advanced refractory glaucoma. Ophthalmology 1997;104:1508-19
  10. Spencer AF, Vernon SA. “Cyclodiode”: results of a standard protocol. Br J Ophthalmol 1999;83:311-6
  11. Pucci V, Marchini G, Pedrotti E, et al. Transscleral diode laser cyclophotocoagulation in refractory glaucoma. Ophthalmologica 2001;215:263-6
  12. Egbert PR, Fiadoyor S, Budenz DL, et al. Diode laser transscleral cyclophotocoagulation as a primary surgical treatment for primary open-angle glaucoma. Arch Ophthalmol. 2001;119:345- 50
  13. Ansari E, Gandhewar J. Long-term effi cacy and visual acuity following transscleral diode laser photocoagulation in cases of refractory and nonrefractory glaucoma. Eye 2007;21:936-40
  14. Vernon SA, Koppens JM, Menon GJ, et al. Diode laser cycloablation in adult glaucoma: long-term results of a standard protocol and review of current literature. Clin Exp Ophthalmol. 2006;34:411-20
  15. Grueb M, Rohrbach JM, Bartz-Schmidt KU, et al. Transscleral diode laser cyclophotocoagulation as primary and secondary surgical treatment in primary open-angle and pseudoexfoliative glaucoma. Long-term clinical outcomes. Graefes Arch Clin Exp Ophthalmol. 2006;244:1293-99
  16. Shah P, Lee GA, Kirwan JK, et al. Cyclodiode photocoagulation for refractory glaucoma after penet